Record Details

CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease The Print dated 20th December 2022

CMFRI Repository

View Archive Info
 
 
Field Value
 
Relation http://eprints.cmfri.org.in/16554/
https://theprint.in/india/cmfri-signs-mou-to-launch-product-from-seaweeds-to-combat-fatty-liver-disease/1272891/
 
Title CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease The Print dated 20th December 2022
 
Creator CMFRI, Library
 
Subject CMFRI News Clippings
 
Description The Central Marine Fisheries Research Institute (CMFRI)has signed an MoU for the production of Cadalmin LivCure extract, a patent-protected nutraceutical product from seaweeds, to combat non-alcoholic fatty liver disease (NAFLD). A Memorandum of Understanding (MoU) was inked with Emineotech, a private limited company dealing with health products, for commercial production and marketing.
 
Publisher The Print
 
Date 2022
 
Type Article
PeerReviewed
 
Format text
 
Language en
 
Identifier http://eprints.cmfri.org.in/16554/1/The%20Print_20-12-2022.pdf
CMFRI, Library (2022) CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease The Print dated 20th December 2022. The Print.